FDA finds quality control problems at Sun Pharma's Halol plant

MUMBAI (Reuters) - The U.S. Food and Drug Administration (FDA) has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report obtained by Reuters shows.